Found: 5
Select item for more details and to access through your institution.
Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00260-0
- By:
- Publication type:
- Article
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.01087
- By:
- Publication type:
- Article
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease.
- Published in:
- BMC Biology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12915-020-00876-3
- By:
- Publication type:
- Article
Bacillus subtilis SepF Binds to the C-Terminus of FtsZ.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043293
- By:
- Publication type:
- Article
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08294-y
- By:
- Publication type:
- Article